Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04371861 · ClinicalTrials.gov registry record

Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.

A clinical trial, sponsored by Terumo Medical Corporation.

Completed
Registry status
120
Enrollment target

NCT04371861 is a clinical trial that has completed, run by Terumo Medical Corporation. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04371861 has completed, sponsored by Terumo Medical Corporation.

COMPLETED
Registry status
120 participants
Enrollment target

Study Summary

This study is designed to collect data on the complication rates and procedural success of using a transradial access approach to treat peripheral lesions in the lower extremities of a real world population.

Interventions

  • DEVICE Peripheral Artery Treatment

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2020-06-29
Est. Completion 2022-06-30

Sponsor

Terumo Medical Corporation

5 total trials

What the Registry Record Tells You About NCT04371861

The ClinicalTrials.gov registry entry for NCT04371861 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terumo Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Peripheral Artery Treatment is the first listed.

NCT04371861 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04371861 about?

NCT04371861 is a clinical study titled "Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.". This study is designed to collect data on the complication rates and procedural success of using a transradial access approach to treat peripheral lesions in the lower extremities of a real world population.

What is the current status of trial NCT04371861?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2020-06-29. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT04371861?

The interventions under investigation include: Peripheral Artery Treatment (DEVICE).

Who is sponsoring clinical trial NCT04371861?

This trial is sponsored by Terumo Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.